Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 6 studies | 28% ± 11% | |
| epithelial cell | 4 studies | 24% ± 4% | |
| astrocyte | 4 studies | 21% ± 4% | |
| GABAergic neuron | 3 studies | 22% ± 4% | |
| glutamatergic neuron | 3 studies | 28% ± 9% | |
| oligodendrocyte | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3595.21 | 1444 / 1445 | 100% | 16.49 | 183 / 183 |
| brain | 100% | 5877.50 | 2641 / 2642 | 100% | 41.25 | 704 / 705 |
| prostate | 100% | 3859.22 | 245 / 245 | 100% | 31.80 | 501 / 502 |
| breast | 100% | 2787.91 | 459 / 459 | 100% | 29.10 | 1113 / 1118 |
| intestine | 100% | 4424.48 | 966 / 966 | 99% | 14.09 | 520 / 527 |
| lung | 99% | 2292.23 | 573 / 578 | 99% | 14.71 | 1144 / 1155 |
| ovary | 98% | 1555.32 | 177 / 180 | 100% | 24.36 | 428 / 430 |
| thymus | 100% | 2748.28 | 652 / 653 | 97% | 19.16 | 586 / 605 |
| stomach | 97% | 2017.01 | 347 / 359 | 98% | 13.85 | 281 / 286 |
| skin | 99% | 2599.09 | 1789 / 1809 | 95% | 18.98 | 448 / 472 |
| uterus | 100% | 2487.78 | 170 / 170 | 93% | 12.31 | 428 / 459 |
| bladder | 100% | 3607.52 | 21 / 21 | 93% | 11.95 | 467 / 504 |
| kidney | 100% | 1899.49 | 89 / 89 | 89% | 14.05 | 805 / 901 |
| adrenal gland | 99% | 2016.98 | 256 / 258 | 88% | 12.64 | 203 / 230 |
| pancreas | 76% | 792.85 | 249 / 328 | 97% | 12.71 | 173 / 178 |
| liver | 97% | 1243.46 | 220 / 226 | 63% | 4.86 | 257 / 406 |
| blood vessel | 100% | 3220.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 11267.46 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1776.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2505.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 93% | 3257.61 | 798 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 10.08 | 41 / 45 |
| eye | 0% | 0 | 0 / 0 | 89% | 11.41 | 71 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 7.44 | 22 / 29 |
| peripheral blood | 26% | 521.85 | 240 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042754 | Biological process | negative regulation of circadian rhythm |
| GO_0048511 | Biological process | rhythmic process |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CIPC |
| Protein name | CLOCK interacting pacemaker CLOCK-interacting pacemaker (CLOCK-interacting circadian protein) |
| Synonyms | KIAA1737 |
| Description | FUNCTION: Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism. May stimulate BMAL1-dependent phosphorylation of CLOCK. However, the physiological relevance of these observations is unsure, since experiments in an animal model showed that CIPC is not critially required for basic circadian clock. . |
| Accessions | ENST00000554447.5 G3V5J4 ENST00000557115.5 ENST00000361786.7 G3V4V0 ENST00000555437.5 ENST00000555200.1 Q9C0C6 ENST00000554658.5 G3V310 ENST00000555611.5 G3V405 G3V5Y7 G3V3Y7 |
